Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07867327
PHASE1

A Study of LY4515100 in Healthy Male Participants

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The main purpose of this study is to evaluate how the body handles \[¹⁴C\]-LY4515100. The study will investigate how much \[¹⁴C\]-LY4515100 enters the bloodstream from the stomach or intestines and is available to have an effect on the body, how the body changes \[¹⁴C\]-LY4515100 so that it can be used or removed, and how the body gets rid of \[¹⁴C\]-LY4515100. For each participant, the study will last about 9 weeks and will include a Clinical Research Unit (CRU) stay lasting between 10 and 30 days.

Official title: A Phase 1, Open-Label, 2-Part Study of the Absorption, Metabolism, Excretion, and Bioavailability of [¹⁴C]-LY4515100 in Healthy Male Participants

Key Details

Gender

MALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

16

Start Date

2026-10

Completion Date

2026-12

Last Updated

2026-10-09

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

[¹⁴C]-LY4515100 Oral Solution

\[¹⁴C\]-LY4515100 administered orally

DRUG

LY4515100 Tablet

LY4515100 administered orally

DRUG

[¹⁴C]-LY4515100 IV

\[¹⁴C\]-LY4515100 administered IV

Locations (1)

Fortrea Clinical Research Unit

Madison, Wisconsin, United States